# Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females

> **NCT03615534** · PHASE4 · COMPLETED · sponsor: **Lewai Sharki Abdulaziz, MSc PhD** · enrollment: 161 (actual)

## Conditions studied

- Atherogenic Dyslipidemia
- Obesity Associated Disorder

## Interventions

- **OTHER:** Therapeutic Lifestyle Changes
- **OTHER:** Placebo
- **DRUG:** Fenofibrate
- **DIETARY_SUPPLEMENT:** Wax Matrix Extended Release Niacin (WMER Niacin)

## Key facts

- **NCT ID:** NCT03615534
- **Lead sponsor:** Lewai Sharki Abdulaziz, MSc PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-01
- **Primary completion:** 2015-06-30
- **Final completion:** 2015-10-30
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2024-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03615534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03615534, "Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03615534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*